ATE421502T1 - Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen - Google Patents
Calciumkanalantagonisten vom n-typ zur behandlung von schmerzenInfo
- Publication number
- ATE421502T1 ATE421502T1 AT01981242T AT01981242T ATE421502T1 AT E421502 T1 ATE421502 T1 AT E421502T1 AT 01981242 T AT01981242 T AT 01981242T AT 01981242 T AT01981242 T AT 01981242T AT E421502 T1 ATE421502 T1 AT E421502T1
- Authority
- AT
- Austria
- Prior art keywords
- pain
- treatment
- type calcium
- calcium channel
- channel antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0004056A SE0004056D0 (sv) | 2000-11-06 | 2000-11-06 | N-type calcium channel antagonists for the treatment of pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE421502T1 true ATE421502T1 (de) | 2009-02-15 |
Family
ID=20281716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01981242T ATE421502T1 (de) | 2000-11-06 | 2001-10-31 | Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6841680B2 (de) |
| EP (1) | EP1339690B1 (de) |
| JP (1) | JP2004513118A (de) |
| AT (1) | ATE421502T1 (de) |
| AU (1) | AU2002212897A1 (de) |
| DE (1) | DE60137534D1 (de) |
| ES (1) | ES2319259T3 (de) |
| SE (1) | SE0004056D0 (de) |
| WO (1) | WO2002036569A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2862301B1 (fr) * | 2003-11-17 | 2007-12-21 | Aventis Pharma Sa | Nouveau procede de preparation de quinoleines 3-fluorees |
| WO2006105670A1 (en) * | 2005-04-08 | 2006-10-12 | Neuromed Pharmaceuticals Ltd. | Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain |
| EP2019676A2 (de) * | 2006-05-11 | 2009-02-04 | Neuromed Pharmaceuticals, Ltd. | Verfahren zur erhöhung der bioverfügbarkeit von benzhydrylpiperazinhaltigen verbindungen |
| SG10201508766UA (en) | 2010-10-29 | 2015-11-27 | Clino Ltd | Tau imaging probe |
| MX2013010306A (es) | 2011-03-08 | 2013-12-09 | Zalicus Pharmaceuticals Ltd | Formulaciones de dispersion solida y metodos de uso de las mismas. |
| US8409560B2 (en) | 2011-03-08 | 2013-04-02 | Zalicus Pharmaceuticals Ltd. | Solid dispersion formulations and methods of use thereof |
| DE102016125645A1 (de) * | 2016-12-23 | 2018-06-28 | Forschungszentrum Jülich GmbH | D-enantiomere Peptide zur Therapie von chronischem und neuropathischem Schmerz |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2114727C (en) * | 1991-08-02 | 1996-12-10 | Mikel P. Moyer | Quinoline derivatives as immunostimulants |
-
2000
- 2000-11-06 SE SE0004056A patent/SE0004056D0/xx unknown
-
2001
- 2001-10-31 AT AT01981242T patent/ATE421502T1/de not_active IP Right Cessation
- 2001-10-31 AU AU2002212897A patent/AU2002212897A1/en not_active Abandoned
- 2001-10-31 JP JP2002539329A patent/JP2004513118A/ja active Pending
- 2001-10-31 WO PCT/SE2001/002391 patent/WO2002036569A1/en not_active Ceased
- 2001-10-31 US US10/415,783 patent/US6841680B2/en not_active Expired - Fee Related
- 2001-10-31 ES ES01981242T patent/ES2319259T3/es not_active Expired - Lifetime
- 2001-10-31 DE DE60137534T patent/DE60137534D1/de not_active Expired - Fee Related
- 2001-10-31 EP EP01981242A patent/EP1339690B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002036569A1 (en) | 2002-05-10 |
| US20040053965A1 (en) | 2004-03-18 |
| AU2002212897A1 (en) | 2002-05-15 |
| DE60137534D1 (de) | 2009-03-12 |
| SE0004056D0 (sv) | 2000-11-06 |
| JP2004513118A (ja) | 2004-04-30 |
| ES2319259T3 (es) | 2009-05-06 |
| US6841680B2 (en) | 2005-01-11 |
| EP1339690A1 (de) | 2003-09-03 |
| EP1339690B1 (de) | 2009-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE323693T1 (de) | Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen | |
| DE60113496D1 (de) | Verwendung von Glycyrrhizin zur Behandlung von Mastitis. | |
| DE60135732D1 (de) | Topoisomerasehemmern zur behandlung von chirurgischen verklebungen | |
| ATE250576T1 (de) | Substituierte pyrrolylverbindungen zur behandlung von entzündungen | |
| DE60117977D1 (de) | Vorrichtungen zur behandlung von harninkontinenz | |
| ES2151599T3 (es) | Acidos hidroxamicos substituidos con arilsulfonamido como inhibidores de matriz metaloproteinasas. | |
| DE69941586D1 (de) | Verwendung von Uridin in Kombination mit Cholin zur Behandlung von Gedächtnisstörungen | |
| SE9900100D0 (sv) | New compounds | |
| CY1107054T1 (el) | Ενωσεις διτοσυλικου αλατος κιναζολινης | |
| DE69917957D1 (de) | Blockcopolymerzusammensetzung für die Modifikation von Asphalt, und Asphaltzusammensetzung enthaltend diese Blockcopolymerzusammensetzung | |
| DE602004017037D1 (de) | 2,3-dihydro-6-nitroimidazoä2,1-büoxazolverbindungen zur behandlung von tuberkulose | |
| DE60101354T2 (de) | Diorganopolysiloxan/Acrylat-Copolymer enthaltende Emulsionen zur Behandlung von Flächengebilden | |
| DE60204232D1 (de) | Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen | |
| DE60139428D1 (de) | Konjugiertes Dienkautschukgel, Kautschukzusammensetzungen die dieses enthalten und Verfahren zur Herstellung von konjugiertem Dienkautschuk | |
| DE69913548D1 (de) | Mglur5 antagonisten zur behandlung von schmerzen und angstzuständen | |
| EP0657942A3 (de) | Lateraler Bipolartransistor. | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE60216495D1 (de) | Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung | |
| CY1108599T1 (el) | Η απλιδινη στην αντιμετωπιση του πολλαπλου μυελωματος | |
| ATE381938T1 (de) | Verwendungen zur behandlung von fsh-verbundenen zuständen mit gnrh antagonisten | |
| SE0004054D0 (sv) | N-type calcium channel antagonists for the treatment of pain | |
| DE60139195D1 (de) | Aktivierbare polymerzusammensetzung, und gegenstände, die diese nutzen | |
| ATE421502T1 (de) | Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen | |
| ATE259791T1 (de) | N-alkyl-ammonium-acetonitril-salze, methoden dazu und zusammensetzungen die diese enthalten | |
| DE60128009D1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |